# Oral Endocannabinoids in People With Prediabetes and Diabetes

> **NCT06040164** · — · UNKNOWN · sponsor: **Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud** · enrollment: 60 (estimated)

## Conditions studied

- PreDiabetes
- Diabetes Mellitus, Type 2
- Obesity
- Oral Dysbiosis
- Mouth Disease

## Interventions

- **OTHER:** Observational study

## Key facts

- **NCT ID:** NCT06040164
- **Lead sponsor:** Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06040164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06040164, "Oral Endocannabinoids in People With Prediabetes and Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06040164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*